NEW YORK, Nov. 22, 2023 /PRNewswire/ — The zinc dust, powders, and flakes market size is expected to grow by USD 456.13 million from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 4.87% during the forecast period, according to Technavio. The growth of the global construction industry… Continue reading Zinc Dust, Powders, And Flakes Market to increase by USD 456.13 million between 2022 to 2027; Altana AG, AVL METAL POWDERS n.v., Cynor Laboratories, and more among key companies – Technavio
Category: Newswire
Motor Protector Market to Reach US$4.34 Billion by 2034 Amidst Growing Automation and Industrialization | Future Market Insights, Inc.
The growing shift towards automation in industries has increased demand for electric motors. As a result, the global motor protector market is projected to grow significantly in the coming decade. This comprehensive report provides valuable guidance for businesses navigating this dynamic landscape by delving into the key drivers, challenges, and investment opportunities shaping the market.… Continue reading Motor Protector Market to Reach US$4.34 Billion by 2034 Amidst Growing Automation and Industrialization | Future Market Insights, Inc.
The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight
B-cell lymphoma, a subtype of non-Hodgkin lymphoma, stands as the leading cancer diagnosis in the United States, comprising 85% of all cases. This cancer targets the lymphatic system, encompassing lymph nodes, vessels, and related tissues responsible for fluid transportation within the body. The outlook for B-cell lymphoma patients has been steadily improving, thanks to ongoing… Continue reading The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight
BEST Inc. Announces Unaudited Third Quarter 2023 Financial Results
HANGZHOU, China, Nov. 22, 2023 /PRNewswire/ — BEST Inc. (NYSE: BEST) (“BEST” or the “Company”), a leading integrated smart supply chain solutions and logistics services provider in China and Southeast Asia (“SEA”), today announced its unaudited financial results for the third quarter ended September 30, 2023. FINANCIAL HIGHLIGHTS[1] For the Third Quarter Ended September 30, 2023:[2]… Continue reading BEST Inc. Announces Unaudited Third Quarter 2023 Financial Results
Algonquin Power & Utilities Corp. Announces Conversion Rights for Cumulative Rate Reset Preferred Shares, Series A
OAKVILLE, ON, Nov. 22, 2023 /PRNewswire/ – Algonquin Power & Utilities Corp. (“AQN” or the “Company”) (TSX: AQN) (NYSE: AQN) announced today that it does not intend to exercise its right to redeem all or part of the currently outstanding 4,800,000 Cumulative Rate Reset Preferred Shares, Series A (the “Series A Preferred Shares”) on January… Continue reading Algonquin Power & Utilities Corp. Announces Conversion Rights for Cumulative Rate Reset Preferred Shares, Series A
Hollysys Update: EGM, Sale Process
– Hollysys intends to hold special meeting of shareholders in January 2024 – Special Committee continues sale process in expedited manner BEIJING, Nov. 22, 2023 /PRNewswire/ — Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) (“Hollysys” or the “Company”) today announced its intention to hold a special meeting of shareholders in the week commencing January 22, 2024… Continue reading Hollysys Update: EGM, Sale Process
Aeglea BioTherapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., Nov. 22, 2023 /PRNewswire/ — Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of inflammatory bowel disease (“IBD”), today announced that Aeglea’s independent Compensation Committee of the Board of Directors approved the grants of stock options to purchase an… Continue reading Aeglea BioTherapeutics Announces Grants of Inducement Awards
X Financial Reports Third Quarter 2023 Unaudited Financial Results
SHENZHEN, China, Nov. 22, 2023 /PRNewswire/ — X Financial (NYSE: XYF) (the “Company” or “we”), a leading online personal finance company in China, today announced its unaudited financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Operational Highlights Three Months Ended September 30, 2022 Three Months Ended June 30, 2023 Three… Continue reading X Financial Reports Third Quarter 2023 Unaudited Financial Results
DigitalBGA Welcomes Richard “Dante” Cantu as Managing Partner
AUSTIN, Texas, Nov. 22, 2023 /PRNewswire/ — DigitalBGA, an innovator in life insurance distribution, is excited to announce the addition of Richard “Dante” Cantu as an equity partner, joining its founders, Jeff Root and Nic West. This strategic move marks a significant milestone for the company, which has been recognized in Inc 5000’s list of… Continue reading DigitalBGA Welcomes Richard “Dante” Cantu as Managing Partner
RTX Announces New Lead Independent Director
ARLINGTON, Va., Nov. 22, 2023 /PRNewswire/ — RTX (NYSE: RTX) today announced the appointment of Fredric G. Reynolds as lead independent director. Mr. Reynolds replaces Dinesh C. Paliwal who will step down from the Board, effective December 1, 2023. “On behalf of the Board, the RTX management team and our shareholders, I would like to thank… Continue reading RTX Announces New Lead Independent Director